1Weinmann M, Brandes A, Classen J, et al. Impressive remission in a patient with locally advanced malignant pleural mesothelioma treated with gemcitabine[ J ]. Anticancer Drugs, 1999,10( 1 ) :33-37.
2Ryan CW, Hemclin J, Vogelzang NJ. A review of chemotherapy trials for malignant mesothelioma[ J]. Chest, 1998 : 113 [ Suppl] :66s-73s.
3Kasseyet S,Astoul P,Boutin C.Resuhs of a phase Ⅱ trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura[J]. Cancer, 1999,85(8) : 1740-1749.
4Halme M, Knvvttila A, Vehmas J, et al. High-dose methotrexate in combination with intefferons in the treatment of malignant pleural mesothelioma[ J] .Br J Cancer, 1999,80(11) : 1781-1785.
5Metintas M, Ozdemir N, Ucgnn I, et el. Cisplatin, mitomycin, and interferon-alpha2a combination chemoimmunotherapy in the treatment of diffuse malignant pleura] mesothelioma [ J]. Chest, 1999, 116(2): 391-398.
6Ong ST,Vogelzang NJ. Chemotherapy in malignant pleural mesothelioma. A review[J] .J Clin Oncol, 1996,14(3) : 1007-1017.
7Parra HS, Tixi L, Latteri F, et al. Combined regimen of cisplatin, doxorubicin ,and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma:a Phase Ⅱ multicenter trial of the ltalian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force( FONICAP ) [ J ]. Cancer, 2001,92 ( 3 ) : 650-656.
8Karrison TG, Vogelzang NJ. Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: a Phase Ⅱ study[ J]. Cancer, 1999,86(3 ) :546-547.
9Aisner J. Current approach to malignant mesothelioma of the pleura[ J ]. Chest, 1995,107 [ Suppl 6] : 332S-344S.
